Ignite Creation Date:
2025-12-24 @ 4:43 PM
Ignite Modification Date:
2026-01-05 @ 2:31 AM
Study NCT ID:
NCT04424966
Status:
TERMINATED
Last Update Posted:
2025-10-24
First Post:
2020-05-27
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Infigratinib in Recurrent High-Grade Glioma Patients
Sponsor:
Nader Sanai
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-07-21
Start Date Type:
ACTUAL
Primary Completion Date:
2023-01-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-02-19
Completion Date Type:
ACTUAL
First Submit Date:
2020-05-27
First Submit QC Date:
None
Study First Post Date:
2020-06-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-07-28
Results First Submit QC Date:
None
Results First Post Date:
2025-10-24
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-29
Last Update Post Date:
2025-10-24
Last Update Post Date Type:
ESTIMATED